A Study of Naltrexone SR/ Bupropion SR in Overweight and Obese Subjects Who Are Nicotine-Dependent

Completed · Phase 2

Conditions studied: Nicotine Dependence, Overweight, Obesity

In brief

The purpose of this study is to determine whether a combination of naltrexone SR and bupropion SR is safe and effective in the treatment of nicotine-dependence in overweight and obese subjects.

Key facts

Study ID

NCT00563563

Run by

Orexigen Therapeutics, Inc

People needed

30

Starts

2007-10-01

Expected to finish

2008-09-01

Last updated by the study team

2012-11-02

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Pharmacology Research Institute — Encino, California, United States
• Pharmacology Research Institute — Los Alamitos, California, United States
• Pharmacology Research Institute — Newport Beach, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.